PLX Technology Inc news

  
Showing stories 1 - 5 of about 5   

Articles published

PLXT 0.0000
price chart
PLx Pharma Files New Drug Application with FDA and Adds New Board Member
HOUSTON--(BUSINESS WIRE)--PLx Pharma Inc., a specialty pharmaceutical company developing a novel aspirin and lipid complex (PL2200 Aspirin 325 mg), reports that the United States Food and Drug Administration (FDA) has accepted for review a new drug ...
A Sleeper Technology Sector Comes Back to Life
Today, the FDA approved ELELYSO™ (taliglucerase alfa) co-developed by Protalix BioTherapeutics (NASDAQ:PLX) and Pfizer (NYSE:PFE) for the treatment of Gaucher disease.
Protalix's FDA Approval And 1-Year Price Target
Protalix Biotherapeutics (NYSEMKT:PLX), partnered with Pfizer (NYSE:PFE), has just received FDA approval for their lead product candidate, ELELYSO (taligucerase alfa), for the treatment of type I Gaucher disease.
GeForce GTX 690 Review: Testing Nvidia's Sexiest Graphics Card
We now know that the GeForce GTX 690's GPUs are linked by a PEX 8747, one of PLX's third-gen, 48-lane, five-port switches manufactured at 40 nm.
ASRock Z77 Extreme9 Motherboard Launched
World's top 3 motherboard maker, ASRock Inc., today excited to launch the company's top-of-the-line Z77 motherboard, model name Z77 Extreme9.